Durata Therapeutics (DRTX) – Analyst Ratings
-
Roth Capital Downgrades Durata Therapeutics (DRTX) to Neutral
-
Credit Suisse Downgrades Durata Therapeutics (DRTX) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DRTX Stock Lookup